185 related articles for article (PubMed ID: 29264043)
21. A patient with coexisting myasthenia gravis and lambert-eaton myasthenic syndrome.
Kim JA; Lim YM; Jang EH; Kim KK
J Clin Neurol; 2012 Sep; 8(3):235-7. PubMed ID: 23091535
[TBL] [Abstract][Full Text] [Related]
22. Lambert-Eaton myasthenic syndrome with primary thymic marginal zone B-cell lymphoma: A case report.
Soma T; Matsumoto A; Shoji T; Katakura H
Respirol Case Rep; 2023 May; 11(5):e01149. PubMed ID: 37082169
[TBL] [Abstract][Full Text] [Related]
23. [Dosage and specificity of anti-calcium channel antibodies in Lambert-Eaton myasthenic syndrome].
Martin-Moutot N; de Haro L; Seagar M
Rev Neurol (Paris); 2004 May; 160(5 Pt 2):S28-34. PubMed ID: 15269657
[TBL] [Abstract][Full Text] [Related]
24. Lambert-Eaton Myasthenic Syndrome Caused by Nivolumab in a Patient with Squamous Cell Lung Cancer.
Nakatani Y; Tanaka N; Enami T; Minami S; Okazaki T; Komuta K
Case Rep Neurol; 2018; 10(3):346-352. PubMed ID: 30627102
[TBL] [Abstract][Full Text] [Related]
25. Lambert-Eaton Myasthenic Syndrome Caused by Atezolizumab in a Patient with Small-cell Lung Cancer.
Kunii E; Owaki S; Yamada K; Yoshihara M; Yamaba Y; Takakuwa O; Toyoda T; Akita K
Intern Med; 2022 Jun; 61(11):1739-1742. PubMed ID: 34707051
[TBL] [Abstract][Full Text] [Related]
26. [Lambert-Eaton myasthenic syndrome (LEMS)].
Suzuki S
Brain Nerve; 2010 Apr; 62(4):419-26. PubMed ID: 20420183
[TBL] [Abstract][Full Text] [Related]
27. 3,4-Diaminopyridine for the treatment of myasthenia gravis with electrophysiological patterns of Lambert-Eaton myasthenic syndrome.
Lee MK; Sunwoo IN; Kim SM
J Clin Neurosci; 2018 Apr; 50():194-198. PubMed ID: 29402568
[TBL] [Abstract][Full Text] [Related]
28. GRP78 antibodies damage the blood-brain barrier and relate to cerebellar degeneration in Lambert-Eaton myasthenic syndrome.
Shimizu F; Takeshita Y; Sano Y; Hamamoto Y; Shiraishi H; Sato T; Yoshimura S; Maeda T; Fujikawa S; Nishihara H; Kitanosono H; Tsujino A; Motomura M; Kanda T
Brain; 2019 Aug; 142(8):2253-2264. PubMed ID: 31236596
[TBL] [Abstract][Full Text] [Related]
29. Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder.
Vincent A; Lang B; Newsom-Davis J
Trends Neurosci; 1989 Dec; 12(12):496-502. PubMed ID: 2480664
[TBL] [Abstract][Full Text] [Related]
30. Spontaneous regression of small cell lung cancer associated with Lambert-Eaton Myasthenic Syndrome: Case report.
Otani M; Nishimori M; Iwasa H; Iwamura M; Izumi T; Nakaji K; Nitta N; Miyatake K; Yoshimatsu R; Yamanishi T; Matsumoto T; Osaki Y; Wada N; Toi M; Yamamoto M; Nakatani Y; Kubota T; Yamagami T
Radiol Case Rep; 2023 Nov; 18(11):4036-4041. PubMed ID: 37680668
[TBL] [Abstract][Full Text] [Related]
31. [Molecular immunology of voltage-gated calcium channel and Lambert-Eaton myasthenic syndrome].
Iwasa K; Komai K; Yasukawa Y; Maruta T; Takamori M
Nihon Rinsho; 1997 Dec; 55(12):3322-30. PubMed ID: 9436458
[TBL] [Abstract][Full Text] [Related]
32. Long-term observation of incremental response and antibodies to voltage-gated calcium channels in patients with Lambert-Eaton myasthenic syndrome: two case reports.
Schneider I; Kornhuber ME; Hanisch F
J Med Case Rep; 2015 Mar; 9():59. PubMed ID: 25885033
[TBL] [Abstract][Full Text] [Related]
33. [A case of cT0N2M0 small cell lung cancer with Lambert-Eaton myasthenic syndrome].
Tsukiji J; Kaneko T; Saito H; Kobayashi M; Kakemizu N; Komatsu S; Nishiyama H; Amano H; Miura K; Satoh T; Shinohara T; Mishima W; Yamakawa Y; Nishihira R; Miyashita A; Noda K; Ishigatsubo Y; Matsuse T
Nihon Kokyuki Gakkai Zasshi; 2004 Sep; 42(9):820-4. PubMed ID: 15500150
[TBL] [Abstract][Full Text] [Related]
34. [Lambert-Eaton myasthenic syndrome: diagnosis and treatment].
Motomura M; Iwanaga H
Clin Calcium; 2001 Nov; 11(11):1468-74. PubMed ID: 15775666
[TBL] [Abstract][Full Text] [Related]
35. The association between Lambert-Eaton myasthenic syndrome and small cell lung carcinoma.
Briggs SE; Gozzard P; Talbot DC
Immunotargets Ther; 2013; 2():31-7. PubMed ID: 27471686
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of intravenous immunoglobulin for treatment of Lambert-Eaton myasthenic syndrome without anti-presynaptic P/Q-type voltage-gated calcium channel antibodies: a case report.
Okada A; Koike H; Nakamura T; Motomura M; Sobue G
Neuromuscul Disord; 2015 Jan; 25(1):70-2. PubMed ID: 25444432
[TBL] [Abstract][Full Text] [Related]
37. [Lambert-Eaton myasthenic syndrome associated with pulmonary squamous cell carcinoma and circulating anti-P/Q-type voltage-gated calcium channel antibody].
Katada E; Nakamura T; Watanabe H; Matsukawa N; Ojika K; Sobue G
Rinsho Shinkeigaku; 2010 Jan; 50(1):17-9. PubMed ID: 20120349
[TBL] [Abstract][Full Text] [Related]
38. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
39. Neuronal antibody detection and improved lung cancer prediction in Lambert-Eaton myasthenic syndrome.
Maddison P; Gozzard P; Sadalage G; Ambrose PA; Chapman CJ; Murray A; Thomsen S; Berretta A; Lang B
J Neuroimmunol; 2020 Mar; 340():577149. PubMed ID: 31951874
[TBL] [Abstract][Full Text] [Related]
40. MG and LEMS overlap syndrome: case report with electrophysiological and immunological evidence.
Oh SJ; Sher E
Clin Neurophysiol; 2005 May; 116(5):1167-71. PubMed ID: 15826858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
